A fatal case of Strongyloides hyperinfection with obscure risk factors
- 17 March 2023
- journal article
- letter
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 42 (5), 1-3
- https://doi.org/10.1007/s10096-023-04588-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trialThe Lancet Infectious Diseases, 2019
- Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State IndiaPLoS Neglected Tropical Diseases, 2019
- Unsuspected Strongyloides stercoralis infection in hospital patients with comorbidity in need of proper managementBMC Infectious Diseases, 2016
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infectionEmergencias, 2016
- Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in SpainActa Tropica, 2015
- Strongyloides stercoralis: Global Distribution and Risk FactorsPLoS Neglected Tropical Diseases, 2013
- Antihelminthic Therapy and Antimony in Cutaneous Leishmaniasis: A Randomized, Double-Blind, Placebo-Controlled Trial in Patients Co-Infected with Helminths and Leishmania braziliensisThe American Journal of Tropical Medicine and Hygiene, 2011
- Efficient control of Leishmania and Strongyloides despite partial suppression of nematode‐induced Th2 response in co‐infected miceParasite Immunology, 2011
- Influence of Helminth Infections on the Clinical Course of and Immune Response toLeishmania braziliensisCutaneous LeishmaniasisThe Journal of Infectious Diseases, 2007
- Strongyloides stercoralisin the Immunocompromised PopulationClinical Microbiology Reviews, 2004